Nebraska
The Department of Health and Human Services announced the COVID-19 Ad-Hoc Schedule 3rd Dose Vaccine Update. Effective date was August 12, 2021.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Department of Health and Human Services announced the COVID-19 Ad-Hoc Schedule 3rd Dose Vaccine Update. Effective date was August 12, 2021.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Centers for Medicare and Medicaid approved the Department of Health and Human Services' State Plan Amendment for Medication-Assisted Treatment (MAT) on August 17. MAT is a covered service for all Medicaid beneficiaries meeting the medical necessity criteria for the service beginning October 1 and ending September 30, 2025.
Also in Nebraska, Provider Bulletin 21-18 includes two important updates:
Finally in Nebraska, the Department of Health and Human Services announced that COVID-19 Medicaid Provider Calls will resume on September 1.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The DUR Board will meet on September 14. The following materials have been posted on the website: agenda, policy statements and July 13, 2021 draft meeting minutes.
Also in Nebraska, the Board of Pharmacy will conduct a conference call meeting on August 16. The agenda with information to access the conference call and a link to the draft regulations (172 NAC 134) related to "delegated dispensing permits" have been posted.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Department of Health and Human Services (DHHS) released recent updates and information including the following:
Also in Nebraska, the draft July 13 minutes from the recent Medicaid DUR Board Meeting and the Board Policy Statements are now available.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The next meeting of the Medicaid DUR Board Meeting will be held on July 13.
Also in Nebraska, given the expansion of testing availability throughout the state and decreased volume of specimens submitted to Test Nebraska, the Department of Health and Human Services announced that Test Nebraska will no longer be collecting COVID-19 specimens after July 18.
Finally in Nebraska, Gov. Pete Ricketts (R) announced the end of the coronavirus state of emergency at 11:59 p.m. on June 30. The Governor issued Executive Order (EO) 21-09 to rescind pandemic-related executive orders. With a few exceptions, the coronavirus executive orders will expire on July 30, which is thirty days after the state of emergency ends. NACDS researched and identified the following as impacting pharmacies, pharmacists, interns and/or technicians and expiring on July 30.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Effective July 1, 2021, the METAVIR fibrosis score required for coverage by Nebraska Medicaid will be changed to F0. The current prior authorization criteria require a METAVIR fibrosis score of at least F2. These changes mean that patients with a METAVIR fibrosis score of F0 may have their prescribed antiviral medications to treat hepatitis C be covered by Nebraska Medicaid. Prior authorization for Hepatitis C antiviral medications will continue to be in place. See Provider Bulletin 21-11 for additional details.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
On May 5, 2021, Gov. Pete Ricketts (R) signed LB 583, requiring Schedule II-V controlled substances prescriptions to be electronically prescribed with exceptions effective January 1, 2022. However, dentists will be required to do so beginning January 1, 2024.
Also in Nebraska, the Department of Health and Human Services published the agenda for the next conference call meeting of the Board of Pharmacy on Monday, May 24, 2021. The March 22 conference call meeting minutes are also available.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The meeting materials for the next meeting of the Drug Utilization Review (DUR) Board on May 11, 2021, have been posted.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The next meeting of the Drug Utilization Review (DUR) Board will be May 11, 2021.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.